Ciclesonide May Ease Sorafenib Resistance in Liver Cancer, Study Suggests
A CRISPR screening-informed five-gene signature identifies liver cancer patients with poor sorafenib response, and ciclesonide emerges as a candidate drug ...
A CRISPR screening-informed five-gene signature identifies liver cancer patients with poor sorafenib response, and ciclesonide emerges as a candidate drug ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.